HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease.

Abstract
Loss of intestinal mucosa integrity is an important factor in the pathogenesis of inflammatory bowel disease (IBD). The aim of this study was to characterize expression changes and allelic variants of genes related to intestinal epithelial barrier function in this disease. Therefore, ileal and colonic mucosal biopsies from nonaffected regions of patients with ulcerative colitis (UC) and Crohn's disease (CD), as well as non-IBD probands, were subjected to Affymetrix DNA-microarray analysis. Real-time reverse transcription polymerase chain reaction was used for verification in larger IBD sample numbers. Disturbed mRNA expression was identified for several mucin genes in both disease groups and tissues. A significant downregulation in the colon was obtained for MUC2 in CD and MUC12 in CD and UC. Expression analysis of all dysregulated mucins in a broad human tissue panel revealed dominant epithelial tissue-specific transcription. In silico analysis of the regulatory regions of these mucins indicated nuclear factor kappaB (NFkappaB) binding sites in each promoter. Furthermore, NFkappaB was overrepresented in mucin promoters and a component of a specific combination of transcription factors (composite module). In vivo stimulation experiments in the adenocarcinoma cell line LS174T showed inducible mucin expression by the cytokines tumor necrosis factor-alpha and transforming growth factor-beta, which could be blocked by NFkappaB signaling inhibitors. Allelic discrimination screening obtained statistically significant associations for the MUC2-V116M (P = 0.003) polymorphism with CD and for MUC4-A585S (P = 0.025), as well as MUC13-R502S (P = 0.0003) with UC. These data suggest that the disturbed expression of mucin genes and the connection to the NFkappaB pathway may influence the integrity of the intestine and therefore contribute to the pathophysiology of IBD.
AuthorsChristoph Moehle, Nikolaus Ackermann, Thomas Langmann, Charalampos Aslanidis, Alexander Kel, Olga Kel-Margoulis, Anna Schmitz-Madry, Alexandra Zahn, Wolfgang Stremmel, Gerd Schmitz
JournalJournal of molecular medicine (Berlin, Germany) (J Mol Med (Berl)) Vol. 84 Issue 12 Pg. 1055-66 (Dec 2006) ISSN: 0946-2716 [Print] Germany
PMID17058067 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MUC13 protein, human
  • MUC2 protein, human
  • MUC4 protein, human
  • Mucin-2
  • Mucin-4
  • Mucins
  • RNA, Messenger
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Base Sequence
  • Biopsy
  • Case-Control Studies
  • Cell Line, Tumor
  • Colitis, Ulcerative (pathology, surgery)
  • Crohn Disease (pathology, surgery)
  • Female
  • Gene Expression Profiling
  • Genetic Variation
  • Humans
  • Inflammatory Bowel Diseases (genetics, surgery)
  • Intestinal Mucosa (metabolism)
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mucin-2
  • Mucin-4
  • Mucins (genetics)
  • RNA, Messenger (metabolism)
  • Sequence Homology, Nucleic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: